Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study: To Assess the Safety, Tolerability and Effects of L-Arginine on Muscles in Boys With Dystrophinopathy on Corticosteroids

NCT01388764 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT01388764
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01388764 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study: To Assess the Safety, Tolerability and Effects of L-Arginine on Muscles in Boys With Dystrophinopathy on Corticosteroids
Lead sponsor
Massachusetts General Hospital
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2012
Completion date
May 31, 2012
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

becker's muscular dystrophy, duchenne muscular dystrophy, dystrophinopathy